HUYA Inc. : The upward trend should continue
BUY
Repli_rebond
Stop-loss triggered
Entry price | Target | Stop-loss | Potential |
---|
US$25.3 |
US$29.58 |
US$24 |
+16.92% |
---|
Shares in HUYA Inc. have recently benefitted from a regain of interest by market participants. The technical chart pattern suggests a continuation of the upward movement.
Summary● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths● Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● Historically, the company has been releasing figures that are above expectations.
● Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at USD 28.8.
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 7.58 times its estimated earnings per share for the ongoing year.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.